151![Submitted Aranesp USPI Aranesp For Injection (darbepoetin alfa) Submitted Aranesp USPI Aranesp For Injection (darbepoetin alfa)](https://www.pdfsearch.io/img/ccd6173b6118209441e3f952b4fc218e.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2009-03-31 15:45:56
|
---|
152![IMPORTANT DRUG WARNING COUNTERFEITING OF PROCRIT� June 6, 2002 Dear Healthcare Professional: IMPORTANT DRUG WARNING COUNTERFEITING OF PROCRIT� June 6, 2002 Dear Healthcare Professional:](https://www.pdfsearch.io/img/fc3658599547e38fc4540a9a681b6d99.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
153![Procrit Label Epogen Label
FDA Approved: [removed]PROCRIT® (Epoetin alfa) Procrit Label Epogen Label
FDA Approved: [removed]PROCRIT® (Epoetin alfa)](https://www.pdfsearch.io/img/b3333769cf27e405055922937a1ac4c7.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2009-03-31 14:49:13
|
---|
154![Aranesp(ß (darbepoetin alfa) For Injection WARNINGS: Erythropoiesis-Stimulating Agents Aranesp(ß (darbepoetin alfa) For Injection WARNINGS: Erythropoiesis-Stimulating Agents](https://www.pdfsearch.io/img/0bd687715eb9478fad43f18cc4cc753a.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2009-03-31 14:49:42
|
---|
155![FOOD AND DRUG ADMINISTRATION (FDA) FOOD AND DRUG ADMINISTRATION (FDA)](https://www.pdfsearch.io/img/dce9fef6c84b0352e85eafb2007a1145.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
156![Aranesp (darbepoetin alfa) Label Aranesp (darbepoetin alfa) Label](https://www.pdfsearch.io/img/0a7eecc73a9d2934d43ff03cf13f3beb.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2009-03-31 14:49:43
|
---|
157![Procrit Label Epogen Label
March 2007 PROCRIT® US PI including CHOIR and AOC updates PROCRIT® (Epoetin alfa) Procrit Label Epogen Label
March 2007 PROCRIT® US PI including CHOIR and AOC updates PROCRIT® (Epoetin alfa)](https://www.pdfsearch.io/img/1818ee1af93dbc3552027a38250841f9.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2009-03-31 14:49:12
|
---|
158![Microsoft Word - FINAL-Peginesatide_questions-v7-rk111205_yw.doc Microsoft Word - FINAL-Peginesatide_questions-v7-rk111205_yw.doc](https://www.pdfsearch.io/img/8a98b3511cf99e31a95d27aaa126482d.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
159![One Amgen Center Drive Thousand Oaks, CA[removed][removed]www.amgen.com January 11, 2005 One Amgen Center Drive Thousand Oaks, CA[removed][removed]www.amgen.com January 11, 2005](https://www.pdfsearch.io/img/366055056fbbebbd603d9bb0b9586413.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
160![One Amgen Center Drive Thousand Oaks, CA[removed][removed]www.amgen.com November 2005 One Amgen Center Drive Thousand Oaks, CA[removed][removed]www.amgen.com November 2005](https://www.pdfsearch.io/img/b5d6b178826fd63528f6c3069ac34e1a.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|